Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot
Recombinant fragments of S proteins from the Severe Acute Respiratory Syndrome (SARS) coronavirus (SARA-CoV) were generated and used in a Western blot (WB) assay that was compared to a commercial SARS ELISA method. In 85% of confirmed SARS cases (n = 20), the S2 recombinant fragment based WB was pos...
Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 113(2004), 2 vom: 29. Nov., Seite 145-50 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , |
Format: | Aufsatz |
Sprache: | English |
Veröffentlicht: |
2004
|
Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.) |
Schlagworte: | Comparative Study Journal Article Research Support, Non-U.S. Gov't Antibodies Antibodies, Viral Membrane Glycoproteins Peptide Fragments Recombinant Proteins Spike Glycoprotein, Coronavirus Viral Envelope Proteins |